Michael Saylor Tokenization Could Create Free Market for Credit and Yield Challenging Traditional Banking Chinas DeepSeek AI Claims CostEfficient Model Training Using Less Advanced Chips Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project UK Exports to US Slump 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges QXO Launches Hostile Takeover Bid for Beacon Building Products After Repeated Rejections Southeast Asias MiddleClass Growth Poses Energy Dilemma RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Stock Decline Entergy Corporation Q1 2026 Earnings Narrow EPS Miss Amidst Operational Stability Farmland Partners Inc FPI Q1 2026 Earnings EPS Misses Estimates by 505 Amid Flat Farmland Market Conditions ABT Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Lower TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status Range Capital Acquisition Corp II Warrants RNGTW Flat at 032 as Warrants Trade Near Support Honda Motor HMC Edges Higher Amid Modest Gains Key Levels in Focus Ohio Valley Banc Corp OVBC Holds Steady Near Support as Volume Remains Tame Neogen Corporation NEOG Edges Higher as Stock Holds Support Zone Rockwell Automation ROK Holds Steady Near Support Amid Modest Gains Ocugen Q1 2026 Earnings EPS Misses Estimates Amid Continued PreClinical Stage Indian Rupee Opens Lower at 9626 Against US Dollar Amid Asian Currency Weakness and RBI Intervention Concerns AList Celebrities Honor Stephen Colberts Final Late Show with First Amendment Tribute Implications for CBS Network Anthropic and Microsoft Explore AI Chip Collaboration Following 5 Billion Investment Gloo Holdings Inc GLOO Q4 2025 Earnings Narrowing Loss Drives Stock Rally Amid Strategic Pivot Kazatomprom Reports 17 Production Surge in Third Quarter Potentially Impacting Uranium Supply MFIN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Silexion Therapeutics SLXN Modest Gains as Stock Holds Key Support at 046